Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
N Engl J Med
    April 2018
  1. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
    Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
    >> Share

  2. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    >> Share

  3. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    >> Share

  4. ZHAO YT, Huang YS
    ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
    N Engl J Med. 2018;378:e22.
    >> Share

  5. AMELOOT K, Daemen J, Van Mieghem N
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360-1.
    >> Share

  6. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    >> Share

  7. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    >> Share

  8. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    >> Share

  9. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    >> Share

  10. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    >> Share


  11. PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-1361.
    >> Share

    March 2018
  12. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
    Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
    N Engl J Med. 2018;378:1043-1053.
    >> Share

  13. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    >> Share

  14. LEE F, Maggiore P, Chung K
    Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
    N Engl J Med. 2018;378:960-962.
    >> Share

    February 2018

  15. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2018;378:782.
    >> Share

    January 2018
  16. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    >> Share

  17. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:345-353.
    >> Share

  18. CAHILL TJ, Wijesurendra RS, Casadei B
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    >> Share

  19. HELFT G, Le Feuvre C, Zaman A
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    >> Share

  20. JEONG YH, Bae JS, Gurbel PA
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:396.
    >> Share

  21. AJANI AE
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-6.
    >> Share


  22. Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-398.
    >> Share

  23. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    >> Share

  24. WEBSTER MWI, Stables RH
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    >> Share

  25. SHAH R
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    >> Share

  26. VIJ A, Kodumuri V
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    >> Share

  27. BULLUCK H
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    >> Share


  28. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298-301.
    >> Share

  29. STONE GW
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:300-1.
    >> Share


  30. Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-202.
    >> Share

  31. LELLOUCHE F, Simon M, L'Her E
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:201.
    >> Share

  32. SAMADANI U, Affana CK
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-1.
    >> Share

  33. ROSENBAUM L
    Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
    N Engl J Med. 2018;378:101-103.
    >> Share

    December 2017
  34. IMPRIALOS KP, Stavropoulos K, Doumas M
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    >> Share

  35. HOLMAN RR, Bethel MA, Hernandez AF
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    >> Share

  36. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
    Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
    N Engl J Med. 2017;377:2475-2484.
    >> Share

  37. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    >> Share

    November 2017

  38. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    >> Share

  39. RAJAGOPALAN S, Brook R
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098-9.
    >> Share

  40. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098.
    >> Share

  41. BAGLIONI P
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-8.
    >> Share

  42. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    >> Share

  43. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    >> Share

  44. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    >> Share

  45. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    >> Share

  46. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    >> Share

  47. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    >> Share


  48. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    >> Share

    October 2017
  49. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    >> Share

  50. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    >> Share

  51. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    >> Share

  52. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    >> Share

  53. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    >> Share

  54. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    >> Share


  55. Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    >> Share

    September 2017
  56. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    >> Share

  57. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    >> Share

  58. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    >> Share

    August 2017
  59. HOFMANN R, James SK, Jernberg T, Lindahl B, et al
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2017 Aug 28. doi: 10.1056/NEJMoa1706222.
    >> Share

  60. LOSCALZO J
    Is Oxygen Therapy Beneficial in Acute Myocardial Infarction? Simple Question, Complicated Mechanism, Simple Answer.
    N Engl J Med. 2017 Aug 28. doi: 10.1056/NEJMe1709250.
    >> Share

  61. ERLINGE D, Omerovic E, Frobert O, Linder R, et al
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMoa1706443.
    >> Share

  62. STONE GW
    Procedural Anticoagulation in Myocardial Infarction.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMe1709247.
    >> Share

  63. EIKELBOOM JW, Connolly SJ, Bosch J, Dagenais GR, et al
    Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMoa1709118.
    >> Share

  64. HARRINGTON RA
    Targeting Inflammation in Coronary Artery Disease.
    N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMe1709904.
    >> Share

  65. REDBERG RF, Prasad V
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:786-7.
    >> Share

  66. NACI H, Mehra MR
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:785-6.
    >> Share

  67. GARCIA DE TENA J, Morales-Ortega A, Pindao-Quesada G
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:785.
    >> Share

  68. NUNES JPL
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:787.
    >> Share

  69. KOSKINAS KC, Windecker S
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:786.
    >> Share

  70. SABATINE MS, Giugliano RP, Pedersen TR
    Evolocumab in Patients with Cardiovascular Disease.
    N Engl J Med. 2017;377:787-8.
    >> Share

  71. SHROYER AL, Hattler B, Wagner TH, Collins JF, et al
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:623-632.
    >> Share

    July 2017
  72. BIBAS L, Thanassoulis G
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:396-7.
    >> Share

  73. FERRANTE G, Stefanini GG
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:397.
    >> Share


  74. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017;377:397-8.
    >> Share

  75. MARTINEZ-CERON E, Garcia-Rio F
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300.
    >> Share


  76. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300-301.
    >> Share

  77. CHRISTEN T, de Mutsert R
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:95.
    >> Share


  78. Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94-96.
    >> Share

  79. XU L, Li D
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94.
    >> Share

  80. MIHAS C, Kantzanou M
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;377:94.
    >> Share

  81. JANI SM, Nallamothu BK, Cooper LT, Smith A, et al
    Beating, Fast and Slow.
    N Engl J Med. 2017;377:72-78.
    >> Share

    June 2017
  82. KONDO T, Terada K
    Coronary-Artery Vasospasm.
    N Engl J Med. 2017;376:e52.
    >> Share

  83. JAISWAL S, Natarajan P, Silver AJ, Gibson CJ, et al
    Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2017 Jun 21. doi: 10.1056/NEJMoa1701719.
    >> Share

  84. WYKRZYKOWSKA JJ, Kraak RP, Hofma SH, van der Schaaf RJ, et al
    Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
    N Engl J Med. 2017;376:2319-2328.
    >> Share

  85. NEAL B, Perkovic V, Mahaffey KW, de Zeeuw D, et al
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017 Jun 12. doi: 10.1056/NEJMoa1611925.
    >> Share

    May 2017
  86. ANDERSON JL, Morrow DA
    Acute Myocardial Infarction.
    N Engl J Med. 2017;376:2053-2064.
    >> Share

  87. DEWEY FE, Gusarova V, Dunbar RL, O'Dushlaine C, et al
    Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
    N Engl J Med. 2017 May 24. doi: 10.1056/NEJMoa1612790.
    >> Share

  88. GRAHAM MJ, Lee RG, Brandt TA, Tai LJ, et al
    Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
    N Engl J Med. 2017 May 24. doi: 10.1056/NEJMoa1701329.
    >> Share

  89. LINCOFF AM, Nicholls SJ, Riesmeyer JS, Barter PJ, et al
    Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    N Engl J Med. 2017;376:1933-1942.
    >> Share

  90. BHATT DL
    Assessment of Stable Coronary Lesions.
    N Engl J Med. 2017;376:1879-1881.
    >> Share

  91. WANG DSH, Mazer CD, Orser BA
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891-2.
    >> Share

  92. JIMENEZ-RIVERA JJ, Iribarren-Sarrias JL, Martinez-Sanz R
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1891.
    >> Share

  93. MYLES PS, Smith JA, Painter T
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1893.
    >> Share

  94. MILOJEVIC M, Kappetein AP, Head SJ
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892.
    >> Share

  95. DAWES TJ, Price S
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2017;376:1892-3.
    >> Share

  96. DAVIES JE, Sen S, Dehbi HM, Al-Lamee R, et al
    Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.
    N Engl J Med. 2017;376:1824-1834.
    >> Share

  97. GOTBERG M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, et al
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI.
    N Engl J Med. 2017;376:1813-1823.
    >> Share

    April 2017
  98. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    >> Share

  99. JENA AB, Mann NC, Wedlund LN, Olenski A, et al
    Delays in Emergency Care and Mortality during Major U.S. Marathons.
    N Engl J Med. 2017;376:1441-1450.
    >> Share

  100. PACKER M, O'Connor C, McMurray JJ, Wittes J, et al
    Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
    N Engl J Med. 2017 Apr 12. doi: 10.1056/NEJMoa1601895.
    >> Share

  101. BANGALORE S, Fayyad R, Laskey R, DeMicco DA, et al
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;376:1332-1340.
    >> Share

  102. KERALIYA A, Blankstein R
    Regression of Coronary Atherosclerosis with Medical Therapy.
    N Engl J Med. 2017;376:1370.
    >> Share

  103. NISSEN SE
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1390.
    >> Share

  104. GROSSER T
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1389.
    >> Share

    March 2017
  105. DEFILIPPIS EM, Vaidya A, Ramani S, French C, et al
    Under Pressure.
    N Engl J Med. 2017;376:e23.
    >> Share

  106. KULLO IJ, Fan X, Ding K
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1192-3.
    >> Share

  107. ELLISON DH
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194.
    >> Share

  108. RAPPAPORT SM, Neophytou AM
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1193.
    >> Share


  109. Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194-5.
    >> Share

  110. MEHTA RH, Leimberger JD, van Diepen S, Meza J, et al
    Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    N Engl J Med. 2017 Mar 19. doi: 10.1056/NEJMoa1616218.
    >> Share

  111. KOBER L
    Complete Revascularization in ST-Elevation Myocardial Infarction?
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMe1702825.
    >> Share

  112. SMITS PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, et al
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMoa1701067.
    >> Share

  113. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
    Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
    >> Share

  114. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    >> Share

  115. DULLAART RP
    PCSK9 Inhibition to Reduce Cardiovascular Events.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMe1703138.
    >> Share

  116. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    >> Share

  117. BELLEYCOTE EP, Lamy AR, Whitlock RP
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1087-8.
    >> Share

  118. CHRISTIANSEN EH, Makikallio T, Holm NR
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1088-9.
    >> Share


  119. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1089.
    >> Share

  120. LIKOSKY DS, Baker RA
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894.
    >> Share

  121. IPP E, Genter P, Childress K
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890-1.
    >> Share


  122. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;379:890-1.
    >> Share

  123. COSMI F, Laini R, Nicolucci A
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890.
    >> Share


  124. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894-895.
    >> Share

  125. WILLIAMS TC, Stewart E
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891.
    >> Share


  126. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891-2.
    >> Share

    December 2016
  127. FARSHID A
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2604.
    >> Share

  128. URBAN P, Oldroyd K, Krackhardt F
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2603-2604.
    >> Share


  129. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602-2605.
    >> Share

  130. BANGALORE S
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
    N Engl J Med. 2016;375:2602-3.
    >> Share

  131. VORA AN, Rao SV, Stone GW
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602.
    >> Share

  132. TAGGART DP, Altman DG, Gray AM, Lees B, et al
    Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.
    N Engl J Med. 2016;375:2540-9.
    >> Share

  133. BATES ER
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2605.
    >> Share

  134. KHERA AV, Emdin CA, Drake I, Natarajan P, et al
    Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.
    N Engl J Med. 2016;375:2349-2358.
    >> Share

  135. O'DONNELL M, Mann JF, Schutte AE, Staessen JA, et al
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    >> Share


  136. Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    >> Share

  137. JOHNS DM
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2407.
    >> Share

  138. GRAUDAL N
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405-6.
    >> Share

  139. ALDERMAN MH
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405.
    >> Share

  140. SNIDERMAN AD, Thanassoulis G
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304.
    >> Share

  141. MORRISON AC, Fu YP, O'Donnell CJ
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303.
    >> Share


  142. Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2306.
    >> Share

  143. STITZIEL NO
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2306.
    >> Share

  144. MORIERI ML, Shah H, Doria A
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304-2305.
    >> Share

  145. HEGELE RA
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2304.
    >> Share

  146. CONTOU D, de Prost N
    Skin Mottling.
    N Engl J Med. 2016;375:2187.
    >> Share

    November 2016
  147. CORREIA LC, Latado A, Porzsolt F
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1798.
    >> Share

  148. COHEN S, Beckey C
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797.
    >> Share


  149. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-1799.
    >> Share

  150. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-8.
    >> Share

    October 2016
  151. BRAUNWALD E
    Treatment of Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  152. STONE GW, Sabik JF, Serruys PW, Simonton CA, et al
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  153. MYLES PS, Smith JA, Forbes A, Silbert B, et al
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2016.
    >> Share

  154. LAMY A, Devereaux PJ, Prabhakaran D, Taggart DP, et al
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016.
    >> Share

  155. MOSLEHI JJ
    Cardiovascular Toxic Effects of Targeted Cancer Therapies.
    N Engl J Med. 2016;375:1457-1467.
    >> Share

  156. BUCHOLZ EM, Butala NM, Ma S, Normand ST, et al
    Life Expectancy after Myocardial Infarction, According to Hospital Performance.
    N Engl J Med. 2016;375:1332-1342.
    >> Share

    September 2016
  157. DWYER T, Sinaiko AR, Raitakari OT
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    >> Share

  158. SHARMA A, Lavie C
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    >> Share


  159. Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    >> Share

  160. MARSO SP, Bain SC, Consoli A, Eliaschewitz FG, et al
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2016.
    >> Share

  161. RAZA S, Blackstone EH, Sabik JF 3rd
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    >> Share

  162. BARBATO E, Toth GG, De Bruyne B
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    >> Share


  163. Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    >> Share

  164. GIANNONI A, Emdin M, Passino C
    Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.
    N Engl J Med. 2016;375:1004-6.
    >> Share

    August 2016
  165. BATES ER
    Balancing the Evidence Base on Coronary Stents.
    N Engl J Med. 2016.
    >> Share

  166. BONAA KH, Mannsverk J, Wiseth R, Aaberge L, et al
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  167. MOKHLESI B, Ayas NT
    Cardiovascular Events in Obstructive Sleep Apnea - Can CPAP Therapy SAVE Lives?
    N Engl J Med. 2016.
    >> Share

  168. MCEVOY RD, Antic NA, Heeley E, Luo Y, et al
    CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.
    N Engl J Med. 2016.
    >> Share

  169. HU K, Xu W, Williams Z
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703-4.
    >> Share

  170. DOEHNER W, Anker SD
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703.
    >> Share

  171. BURSZTYN M
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:702-3.
    >> Share

  172. VISCOLI CM, Kernan WN, Young LH
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:704.
    >> Share

  173. BROTT TG, Voeks JH, Howard VJ
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:604-5.
    >> Share

  174. HUSSAIN MA, Al-Omran M
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603.
    >> Share

  175. PARASKEVAS KI
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:602.
    >> Share

  176. SAMANTA A, Afzal MR
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:601-2.
    >> Share

  177. MATSUMURA J, Monteleone P, Rosenfield K
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603-4.
    >> Share

  178. CHEN GC, Qin LQ
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    >> Share

  179. KOPEL E
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    >> Share

  180. LEOW MK
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:487-8.
    >> Share

  181. DU H, Li L, Chen Z
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:489.
    >> Share


  182. Sharing Data from Cardiovascular Clinical Trials--A Proposal.
    N Engl J Med. 2016;375:407-9.
    >> Share

    July 2016

  183. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
    N Engl J Med. 2016;375:398.
    >> Share

  184. BASSAN M
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292-3.
    >> Share

  185. WANITSCHEK MM, Dorler J, Alber HF
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292.
    >> Share

  186. OHMAN EM
    Chronic Stable Angina.
    N Engl J Med. 2016;375:293.
    >> Share

  187. LI WW, Wollersheim LW, Morshuis WJ
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91.
    >> Share

  188. ALKHODAIR A, Cairns J
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:90-1.
    >> Share

  189. MYLES PS, Smith JA, Painter T
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91-2.
    >> Share

    June 2016
  190. MARSO SP, Daniels GH, Brown-Frandsen K, Kristensen P, et al
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016.
    >> Share

  191. RADEMAKERS LM, Van Nunen LX
    IMAGES IN CLINICAL MEDICINE. Ventricular Septal Defect after Acute Myocardial Infarction.
    N Engl J Med. 2016;374:e28.
    >> Share

  192. COGSWELL ME, Mugavero K, Bowman BA, Frieden TR, et al
    Dietary Sodium and Cardiovascular Disease Risk - Measurement Matters.
    N Engl J Med. 2016.
    >> Share

    May 2016
  193. ALEXANDER JH, Smith PK
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;374:1954-64.
    >> Share

  194. NIOI P, Sigurdsson A, Thorleifsson G, Helgason H, et al
    Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share

  195. TYBJAERG-HANSEN A
    The Sialylation Pathway and Coronary Artery Disease.
    N Engl J Med. 2016.
    >> Share


  196. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    N Engl J Med. 2016;374:1898.
    >> Share

  197. SAPP JL, Wells GA, Parkash R, Stevenson WG, et al
    Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    N Engl J Med. 2016.
    >> Share

    April 2016
  198. MICHLER RE, Smith PK, Parides MK, Ailawadi G, et al
    Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
    N Engl J Med. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016